<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02509871</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A00633-46</org_study_id>
    <nct_id>NCT02509871</nct_id>
  </id_info>
  <brief_title>Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)</brief_title>
  <acronym>MetaCa2</acronym>
  <official_title>Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Jean Perrin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Jean Perrin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This cross-sectional study of pathophysiology will bring additional informations on body
      composition of patients treated by adjuvant hormonal therapy for breast cancer. This is a
      complementary study of Metaca study (AU882).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measure of body composition</measure>
    <time_frame>After more than a year of hormonal therapy</time_frame>
    <description>To obtain additional data to those of Metaca study (AU882) to assess changes in body composition (fat mass, lean body mass in Kg) in women with breast cancer and treated with adjuvant hormonal therapy following chemotherapy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the distribution of abdominal fat by measuring the waist and hip circumference</measure>
    <time_frame>After more than a year of hormonal therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of anxiety and depression scores measured by Questionnaire HAD</measure>
    <time_frame>After more than a year of hormonal therapy</time_frame>
    <description>Questionnaire HAD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of quality of life measured by Questionnaire (QLQ-C30)</measure>
    <time_frame>After more than a year of hormonal therapy</time_frame>
    <description>Questionnaire (QLQ-C30)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the time sitting measured by Questionnaire IPAQ</measure>
    <time_frame>After more than a year of hormonal therapy</time_frame>
    <description>Questionnaire IPAQ</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the change in body composition longitudinally from the data of the study Metaca</measure>
    <time_frame>Between after 1 and 6 months after chemotherapy and after more than a year of hormonal therapy</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Hormonal Therapy</condition>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Body composition measurement</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>DXA, impedance</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Body composition measurement</intervention_name>
    <description>DXA, impedance</description>
    <arm_group_label>Body composition measurement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  postmenopausal women

          -  patients requiring hormonal treatment

          -  WHO performance status 0-2

          -  patients initially included in MetaCa (AU882) protocol

          -  Affiliation to a social security scheme (or be the beneficiary of such a plan)

          -  patients who signed the informed consent form

        Exclusion Criteria:

          -  patients witg relapse, with metastases or other cancer

          -  concurrent treatment with a drug test, or participation in a clinical trial within &lt;
             30 days

          -  patients carrying an electronic medical device (eg pacemaker)

          -  patients who refused to sign the consent form
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier DURANDO, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Jean Perrin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Jean Perrin</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63011</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2015</study_first_submitted>
  <study_first_submitted_qc>July 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2015</study_first_posted>
  <last_update_submitted>December 13, 2016</last_update_submitted>
  <last_update_submitted_qc>December 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Body composition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

